Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase

BACKGROUND: Topoisomerase I (Topo I) poisons (e.g., camptothecin (CPT)), used to treat cancer, cause DNA breaks that are most cytotoxic during S phase. PARP-1 promotes DNA repair and PARP inhibitors (PARPi) sensitise cells to Topo I poisons. We aimed to determine whether chemosensitisation is also S...

Descripción completa

Detalles Bibliográficos
Autores principales: Znojek, P, Willmore, E, Curtin, N J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183837/
https://www.ncbi.nlm.nih.gov/pubmed/25003660
http://dx.doi.org/10.1038/bjc.2014.378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183837/
https://www.ncbi.nlm.nih.gov/pubmed/25003660
http://dx.doi.org/10.1038/bjc.2014.378

Ejemplares similares